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Abstract
Adrenomedullin (AM) has been characterized as an endogenous tissue survival factor and mod-
ulator of many inflammatory processes. Because of the increased susceptibility of the mammary
gland to infection during the time surrounding parturition in the cow, we investigated how milk and
tissue content of AM and its binding protein (AM-BP) might be affected by the stage of lactation
and the udder health status. Milk and mammary biopsy samples were obtained from Holstein cows
21 days prior to and at various times after calving to represent the dry period and early and mid-
stages of lactation. Additional cows received an intramammary challenge with Escherichia coli for
immunohistochemical characterization of AM and AM-BP. Milk AM concentrations were relatively
constant across the stages of lactation while AM-BP increased two-fold (P < 0.04) between early and
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mid-lactation. Milk AM (P< 0.04) and AM-BP (P< 0.03) increased as somatic cell counts (SCCs)
increased within a given stage of lactation. Tissue content of both (AM and AM-BP) were signifi-
cantly affected by stage of lactation, lowest in the dry period and progressively increasing to peak at
mid-lactation as well as increasing in association with higher levels of SCCs. Following E. coli chal-
lenge, AM increased in epithelial cells surrounding mammary alveoli presenting high levels of SCCs.
The data suggest that AM and AM-BP are cooperatively regulated in the mammary gland during
lactation; changes in localized tissue AM and AM-BP content reflect a dynamic regulation of these
tissue factors in the bovine mammary gland consistent with their protective effects within inflamed
tissue.
Published by Elsevier Inc.
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1. Introduction
Adrenomedullin (AM) is a 50-to-52 amino acid peptide, present in a myriad of tissues
and is a member of the calcitonin gene-related (CGRP) family of bioactive peptides [1–3].
Following its discovery and characterization as a potent regulator of cardiovascular func-
tion [4,5], AM is now credited with a multiplicity of effects including autocrine growth
regulation, angiogenesis and neoplasia, tissue differentiation and development, and regu-
lation of metabolism [3]. More recently AM has been called a tissue survival factor [6] in
that its upregulation during periods of proinflammatory stress has been linked to decreased
apoptotic events [7], maintenance of tissue perfusion [8], localized antimicrobial peptide
effects [9,10] and modulation of immune function [6,11]. Many actions of AM are tied
to its interaction with the proinflammatory cytokine cascade including its regulation by
endotoxin (LPS) and tumor necrosis factor- (TNF-, [12,13]), as well as the generation
of nitric oxide via several of the isoforms of nitric oxide synthase (NOS, [13–15]). We
recently characterized a circulating protein that functions as a transport binding protein for
AM (AM-BP, [16]). Further research into this binding protein revealed it to be a member
of the complement cascade, namely, complement factor-H (C-FH, [17]). The interaction of
AM with AM-BP/C-FH results in the modulation of the bioactivity of each component of
the complex [17–19].
Cooperative work between our laboratories indicated that AM was present in several
biofluids including human and bovine milk [20]. Because of its multiple effects on tissue
function and survival as well as its properties as an antimicrobial peptide, we were interested
to determine whether AM levels in bovine milk and mammary tissue might be associated
with or reflective of the changes in udder health status and general mammary physiol-
ogy that have been documented with regard to the impact of stage of lactation, especially
around calving and presence of mammary infection [21–23]. Employing immunohisto-
chemical image analysis techniques as well as RIA and Western blot approaches, we report
here for the first time quantified localized changes in tissue AM and AM-BP in mam-
mary tissue of cows, as well as changes in concentrations of AM and AM-BP in milk
as a function of lactational status, milk somatic cell count, or presence of intramammary
infection.
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2. Materials and methods
2.1. Animals, milk samples and tissue specimen collection
All cows used in this study were from the dairy herd of the Beltsville Agricultural
Research Center. Cows were fed ad libitum, a herd diet (total mixed ration) that was for-
mulated to meet National Research Council requirements for lactating cows. Water was
available ad libitum by automated watering cups. Cows used for mammary biopsy were
maintained in tie stalls for the duration of the experiment, while other cows were maintained
in a free-stall environment. The Beltsville Agricultural Research Center’s Animal Care and
Use Committee approved the protocols, objectives and use of animals for this investigation.
To assess concentrations of AM in bovine milk during early and mid-lactation, milk
samples were obtained from 26 lactating Holstein cows. Milk was collected at a single
morning milking from 13 randomly selected cows during early lactation (12–62 days in
milk), and 13 randomly selected cows during mid-lactation (124–198 days in milk). The
milk samples were composited from the four quarters of each cow at the morning milking
and aliquots prepared for determination of SCC, and analysis of AM and AM-BP. For
determination of milk somatic cell count (SCC), milk samples were heated for 15 min at
60 ◦C and maintained at 40 ◦C until assayed on a Bentley Somacount 150 (Chaska, MN;
[24]). Aliquots for AM and AM-BP analyses were kept on ice and processed within 2 h, as
described subsequently. Milk weights were recorded at the morning and evening milkings.
Expression of AM was studied in mammary tissue obtained during the nonlactating
period (dry period) preceding successive lactations and during lactation. Five cows were
dried-off 60 days before expected parturition and tissue obtained by mammary biopsy of
the rear quarters 8 and 21 days after cessation of milking. Secretory tissue was obtained
by biopsy from the right rear quarters prior to Escherichia coli injection as control samples
and the challenged left rear quarters were biopsied 24 h after bacterial infusion. Biopsies
(∼0.5–1 g tissue) were obtained from the upper half of the glands, using the biopsy method
described by Farr et al. [25]. Mammary tissue was obtained from lactating cows associated
with a previously reported experiment [26]. Tissues from lactating cows were collected
at slaughter from four cows at days 14, 90 and 120 of lactation. Tissues were fixed in
10% neutral-buffered formalin at 4 ◦C overnight and processed for paraffin embedding and
sectioning according to standard methods.
To evaluate the impact of coliform mastitis on expression of AM, tissues were obtained
from three lactating Holstein cows during a previously reported experiment [27]. Briefly,
at the beginning of the study all mammary quarters were healthy and noninfected. Prior
to bacterial infusion, there was no difference in SCC between quarters used for control
samples (right rear) and those used for postinfection analysis (left rear). E. coli challenge
was performed immediately after a specified morning milking by gentle injection of a 2-ml
volume containing 500 colony forming units of E. coli inoculum into the gland sinus of
left front and left rear mammary quarters. The organism used was a serum-resistant E. coli,
strain P-4, serotype O32:H37, which originally had been recovered from a cow with clinical
mastitis and has been used in studies of E. coli mastitis. Secretory tissue was obtained by
biopsy from the right rear quarters prior to E. coli injection as control samples and the
challenged rear quarters were biopsied 24 h after bacterial injection from the upper half of
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the gland using the biopsy method described by Farr et al. [25]. For immunohistochemical
analysis, biopsied tissues were placed in 10% neutral-buffered formalin and fixed at 4 ◦C
overnight. Tissues were then processed for paraffin embedding and sectioning according to
standard methods.
2.2. Analytical techniques
2.2.1. Radioimmunoassay of milk adrenomedullin
Milk concentrations of AM immunoreactivity were measured by a specific RIA as pre-
viously described and validated for plasma and milk [13,20]. Freshly obtained milk was
maintained on ice and processed for AM extraction within 2 h of sampling. All procedures
associated with AM were performed in polypropylene tubes. For extraction, 2.0 ml milk
was centrifuged for 10 min at 4 ◦C to separate milk fat, serum, and solids. Exactly 1.0 ml of
milk serum was drawn from under the fat and mixed with 1.0 ml phosphate buffered saline
(pH 7.4) containing 0.1% peptide matrix derived from the alkaline hydrolysis of casein
(AHC) as described by Livesey and Donald [28] for the control of nonspecific adsorption
of AM onto inert surfaces and other proteins and 0.1% Triton X-100. Extraction of AM was
performed by reverse phase chromatography using C-18 SepPak® cartridges (Waters Cor-
poration, Milford, MA) preconditioned with chloroform, methanol, 80% methanol/water,
with a final prerinse with 1.8% NaCl. The 2.0 ml milk/AHC mixture was allowed to per-
meate through the SepPak over 5 min and flushed with 3.0 ml of 1.8% NaCl. AM was
eluted from the column with 5.0 ml 80% isopropanol in water. The resolved matrix was
frozen in dry ice, and lyophilized to dryness overnight. For assay, the extraction residue
was reconstituted in 400l EDTA-PBS buffer containing 0.1% AHC and 0.05% Triton
X-100 and 20 mg/l phenol red. Samples displaying a yellow color after reconstitution were
neutralized to approximately pH 7.5 (pink color) using <5l 0.1 M NaOH. The solution
was transferred to 1.5 ml conical microfuge tubes and centrifuged at 14,000 rpm for 10 min.
One hundred microliters of each sample were assayed in triplicate in a total assay volume
of 300l (100l sample, 100l 125I-AM tracer, 100l primary antibody). AM for stan-
dards (human AM 1–52), radiotracer (125I-hAM) as well as antibody (rabbit anti-human
AM) were procured from Phoenix Pharmaceuticals, Inc. (Belmont, CA). All samples were
analyzed in a single assay with a coefficient of variation between duplicates of 11.1%, and
a recovery of AM added to milk prior to extraction of 69% and a recovery of AM added to
assay tubes of 97%. Data are reported as assayed values corrected for average pre-extraction
recovery.
2.2.2. Western blot analysis of milk adrenomedullin binding protein
Previous data derived from mass spectroscopy proteomic analysis of isolated and purified
AM-BP has demonstrated that AM-BP and complement factor-H are one and the same [17],
and that the initial localization and quantification of AM-BP by 125I-AM ligand blot [16]
coincided with that derivable using Western blot analysis based on antibody against C-FH
[30]. Therefore, milk levels of AM-BP were measured by Western blot using rabbit anti-
human C-FH (Serotec, Raleigh, NC) as the primary antibody. Milk samples were diluted
1:5 in pure water and centrifuged at 109,000 × g for 20 min at 4 ◦C, and further diluted
at equal parts with Laemmli buffer (125 mM Tris–HCl, 10% SDS, 10% glycerol, pH 6.8,
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bromphenol blue tracking dye; final milk dilution, 1:10) containing 10%-mercaptoethanol.
Samples were incubated in a boiling water bath for 5 min and cooled to room temperature.
Proteins, electrophoretically separated through 8% acrylamide gels for 1.5 h at 110 V, were
transferred to polyvinylidene difluoride (PVDF, Immobilon-PTM, Millipore Corp., Bed-
ford, MA) membranes in a semi-dry electrotransfer apparatus (Bio-Rad, Hercules, CA).
Membranes were incubated with primary antibody diluted 1:2000. Specific AM-BP bands
were resolved using horseradish peroxidase-coupled secondary anti-rabbit antibodies and
a fluorescent substrate (ECL-plus, GE Healthcare, Piscataway, NJ). Fluorescence intensity
was measured using a Typhoon® 9400 variable mode imager (GE Healthcare, Piscataway,
NJ) with band intensities determined and analyzed using ImageQuant® software.
2.2.3. Quantitative immunohistochemistry for adrenomedullin and adrenomedullin
binding protein
Antibodies for AM and AM-BP immunohistochemistry were rabbit anti-AM (P-072,
1:1000 dilution; [29]) and rabbit anti-human C-FH (Serotec, Raleigh, NC, 1:2000 dilution;
[30]). Mammary biopsy samples were embedded in paraffin, sectioned at 5m and mounted
on glass slides. Tissues were dewaxed in two successive 5 min xylene baths followed by
one wash in absolute ethanol and a 30 min incubation in methanolic–3% hydrogen perox-
ide to eliminate endogenous tissue peroxidase activity. Specimens were rehydrated through
decreasing ethanol concentrations to water, transferred to Tris-buffered saline containing
0.05% Triton X-100 for 10 min followed by two 10 min baths in TRIS-saline. Nonspe-
cific binding was blocked using 5% normal goat serum in Tris-saline (1 h), followed by
incubation overnight with the respective primary antibodies (∼16 h, 4 ◦C). Antigens were
visualized using the ABC method (Vectastain Elete® Rabbit Antibody Kit, Vector Labora-
tories, Burlingame, CA) with DAB as the substrate. Nuclei were counterstained for 2 min
using Carazzi’s hematoxylin. Slides were dehydrated through absolute ethanol, dipped in
xylene and covered with glass cover slips. Quantitative image analysis for each antigen was
performed as previously validated and published in our laboratory [31,32]. Three fields for
each of 3 biopsy specimens per slide for each animal were captured using an Olympus BX-
40 microscope (60× oil objective) fitted with an Olympus DP-70 digital camera. In order
to ensure uniformity of the digital analysis of each slide, all images for a given antigen and
for each animal were composed into a master image using Adobe Photoshop®CS (Adobe
Systems, Inc., San Jose, CA), and that master image subjected to the image analysis pro-
cess. The individual frames of the composite image were then analyzed using the Image-Pro
Plus Image Analysis Software (Version 4.5.1, MediaCybernetics Inc. Silver Spring, MD)
through a standardized protocol. The composite images were equalized in terms of contrast,
brightness, and gamma using the software-driven internal best-fit equalization algorithm.
The intensity of DAB color-specific staining was obtained by defining through color-cube-
based segmentation a spectrum-specific range of wavelengths, hues, and intensities that
corresponded to those color attributes detectable by the same staining procedure applied
to an internal control (pancreas) specimen known to contain positive immunostaining for
AM and AM-BP. This spectral information was filed into a retrievable *.rge format that
was subsequently used for analyzing all images. Specificity of staining was further refined
in the software application cut-off criteria where object counts lower than a 3 × 3 pixel unit
were eliminated. As defined in this manner, this analytical solution was found to be most
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commonly associated with false negative staining thus minimizing errors of false positive
inclusion through this conservative rubric. Each estimate of tissue antigen staining intensity
for an individual animal was obtained as the average of the summated pixels/field of the
five images captured for each of two different tissue or biopsy specimens per slide. Because
the mean number of cells per field may have differed as a function of mammary alveolar
area (i.e., larger alveolar area in healthy mid-lactation glands may have resulted in a lower
number of cells per field), additional image capture was obtained through the microscope
as fitted with either the 60× and/or 100× objectives. In these instances, additional pixel
counting was also performed on individual cells as marked using the free-form tool to
outline cell membranes. Additional insight regarding populations of cells associated with
defined mammary architecture and location (infiltrating somatic cells and alveolar epithe-
lial cells) was obtained. Because many of the infiltrate cell types were immune cells with
high intrinsic peroxidase activity, the completeness of peroxidase activity destruction by the
methanolic peroxide incubation step was validated by not adding either primary antibody to
a set of mammary tissue slides. Following the DAB reaction, the validation slides showed
no color development substantiating the fact that color development in the SCC and alveolar
infiltrating cells was specifically associated with an antigen–antibody reaction.
2.2.4. Adrenomedullin in situ hybridization
Assessment of tissue patterns of mRNA for AM was performed by in situ hybridization as
described by Montuenga et al. [33]. We employed the full length AM cDNA ligated into the
pCRII expression vector to generate the needed riboprobes. Generated plasmids were used
as a template to assemble digoxigenin-labeled sense and antisense probes. The effects of
infection on tissue patterns of AM mRNA were tested on mammary biopsy tissue obtained
from the udder quarters of lactating Holstein cows challenged (infected) or not challenged
with E. coli as described earlier in this manuscript. Following fixation, specimens were
embedded in paraffin, sectioned (5m) and mounted on slides using RNAase-protection
protocols. Following xylene removal of paraffin, serial sections of tissue specimens were
permeabilized with proteinase K (10g/ml; 15 min with glycine quenching), acetylated
with 0.25% acetic anhydride, washed and incubated in a humidified chamber (18 h; 46 ◦C)
with the sense and antisense probes, respectively. Following three rounds of stringency
washes, mRNA was visualized using alkaline phosphatase-labeled anti-digoxigenin and
BCIP-NBT as substrate.
2.3. Statistical analysis of data
Data were statistically analyzed using the general linear models procedure of the Statis-
tical Analysis System (Proc GLM; [34]). For sections of the experiment dealing with the
effects of lactation, the main effects tested were stage or day of lactation and SCC with
stage-by-SCC tested for interaction. Animals were stratified and classed according to stage
(early, <60 days after calving; mid-, >60 and <200 days after calving) or day (day 8, 21 of
dry period, day 14, day 90, day 120 after calving) of lactation or SCC ranking (group1, SCC
between 0 and 25,000; group 2 between 26,000 and 100,000; group 3 > 101,000 cells/ml
milk). Justification for this stratification was largely empiric based on whether or not infil-
trating mammary SCCs were not evident (group 1), rarely evident (group 2) or present in
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low numbers in several mammary alveoli evaluated in microscopic examination, though
nonclinical in presentation (group 3). Animal within stage was used as the random error
term.
3. Results
3.1. Milk AM concentration and AM-BP content during lactation
Concentrations of AM in milk did not differ between the early and mid-stages of lactation
(Fig. 1). Concentrations of AM were relatively constant averaging approximately 250 pg/ml.
Concentrations of AM were, however, significantly affected by the prevailing somatic cell
count within a given stage. Collectively, AM concentrations in milk increased with higher
cell counts (P < 0.04). There was a significant stage-by-SCC interaction (P < 0.03).
Data generated by Western blot analysis of milk proteins to measure changes in the con-
tent of AM-BP are presented in Fig. 2. Milk AM-BP level was 2.2-fold higher (P < 0.04) in
mid-lactation than that quantified for milk from cows in early lactation. Similar to the
changes in AM that were associated with somatic cell count, milk AM-BP level was
also affected by somatic cell count (P< 0.03). Milk AM-BP was not statistically differ-
ent between groups 1 and 2; mean milk AM-BP was two-fold higher in milk from cows
presenting somatic cell counts greater than 100,000 cells/ml (group 3) than that associated
with milk from groups 1 and 2. As with milk AM concentrations, there was a significant
stage-by-SCC interaction for milk levels of AM-BP.
3.2. Immunohistochemical localization of AM and AM-BP in the mammary gland
The cellular presentation of AM in mammary tissue at the indicated stages or days of lac-
tation as well as the summarized statistical quantification of antigen-specific colored pixels
Fig. 1. Concentrations of adrenomedullin in milk in early and mid-lactation and as affected by grouping by somatic
cell counts. Bars represent least squares mean values (±pooled S.E.) of 12 cows at early and 14 cows at mid-
lactation; numbers within the bars associated with the graphic section from somatic cell count effects represent
the group identities as segregated by the cell count ranges shown (group 1, n = 11; group 2, n = 7; group 3, n = 8).
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Fig. 2. Concentrations of adrenomedullin binding protein (AB-BP) in milk in early and mid-lactation and as
affected by grouping by somatic cell counts. Panel (A) Representatative Western blot of AM-BP/complement
factor-H in milk from 12 animals at different stages of lactation and somatic cell count values. Panel (B) Bars
represent least squares mean values (±pooled S.E.) of 12 cows at early and 12 cows at mid-lactation; numbers
within the bars associated with the graphic section from somatic cell count effects represent the group identities
as segregated by the cell count ranges shown (group 1, n = 11; group 2, n = 7; group 3, n = 8).
are presented in Fig. 3. Whereas the upper panel of the microphotographs clearly depicts
true antigen immunostaining (DAB, brownish-red color) contrasting with the Carrazzi’s
hematoxylin-stained nuclei, the lower panel depicts in red the pixels that the image analysis
algorithm has identified as counted in association with the antigen. The image shows that
Fig. 3. Tissue AM antigen presentation as quantified by digital image analysis in mammary biopsy tissue from Hol-
stein cows at different physiological stages and days into lactation. (Top panel) Direct immunohistochemical (IHC)
microphotographs obtained using rabbit anti-AM primary antibody with avidin–biotin enhanced visualization
accomplished with a horseradish peroxidase–DAB (reddish-brown color) reaction. (Bottom panel) Representative
output (red pixels) from the image analysis algorithm used to quantify specific DAB immunostaining. (Right
panel) Statistical representation of collated IHC image analysis data. N = 3–4 cows per group; 3–4 biopsy samples
per cow.
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Fig. 4. Tissue AM-BP antigen presentation as quantified by digital image analysis in mammary biopsy tissue
from Holstein cows at different physiological stages and days into lactation. (Top panel) Direct immunohis-
tochemical (IHC) microphotographs obtained using rabbit anti-complement factor-H/AM-BP primary antibody
with avidin–biotin enhanced visualization accomplished with a horseradish peroxidase–DAB (reddish-brown
color) reaction. (Bottom panel) Representative output (red pixels) from the image analysis algorithm used to
quantify specific DAB immunostaining. (Right panel) Statistical representation of collated IHC image analysis
data. N = 3–4 cows per group; 3–4 biopsy samples per cow.
AM is mainly associated with the epithelial cells lining the lumen of the mammary secre-
tory alveoli, as well as some individual somatic cells identified as infiltrating neutrophils
(based upon morphological criteria) within the alveolar lumen. Furthermore, the intensity
of staining (i.e., antigen presence) is lowest in tissue from animals in the dry period and
almost doubled in intensity (pixel density) from day 14 of lactation through day 120 (bar
graph segment of Fig. 3).
The accompanying AM transport protein AM-BP was localized in a cellular pattern
similar to that observed for AM (Fig. 4). Though lower in intensity than the corresponding
AM immunostaining, the consistent significant pattern for AM-BP indicated almost no
presence in tissues of animals in the dry period, again, with antigen localization increasing
with days into lactation to a maximum at mid-lactation. Analysis of data by a separation
on means indicated no difference in AM-BP levels between the dry period and day 14 of
lactation; however, levels significantly higher than these were evident at days 90 and 120
into lactation with a further significant increase developing between days 90 and 120. The
increase at measured peak was approximately seven-fold higher than that quantified for
samples from cows in the dry period or day 14 (P < 0.006).
3.3. AM and AM-BP responses to E. coli challenge in the mammary gland
Image analysis of photomicrographs of responses in AM and AM-BP within the mam-
mary gland to experimental infection withE. coli indicated that AM increased in conjunction
with a decrease in AM-BP (Fig. 5). Consistent with the previously observed increase in tissue
AM with increased SCC in otherwise healthy animals, the challenge with E. coli prompted
an increase in tissue AM from two sources: somatic cells infiltrating the gland and a relative
increase in epithelial presence marked by less diffuse punctuate and more tightly condensed
granules of a larger area (volume). Statistical analysis of the image analysis quantification
data indicated that the AM response to E. coli challenge constituted a three-fold increase in
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Fig. 5. Adrenomedullin and AM-BP response in mammary tissue biopsy samples typical of those mammary
quarters that served as normal and infected with E. coli. The areas designated as “A” indicate luminal areas of the
glandular structure; areas denoted by “B” indicate the presence of infiltrating SCCs.
AM in the mammary epithelial cells, not counting the larger increase in AM in the infiltrat-
ing SCC. In contrast, antigen levels of AM-BP decreased by 70% (P < 0.02) in mammary
epithelial luminal cells; Where detectable in individual SCC, the AM-BP antigen density
levels measured where detectable in individual SCC (using a free-form outlining tool in
the Image-Pro analytical software) were approximately twice the density of epithelial cells
expressing AM-BP. Interestingly, the response in the SCC was an all-or-nothing response
where cells either had high levels of antigen or none at all.
Corroboration on the effect of the coliform-associated inflammatory response on AM
within the challenged mammary quarters was made by assessing the regulatory status of the
infection on AM mRNA expression via in situ hybridization. As presented in Fig. 6, when
the antisense probe was hybridized to mammary AM mRNA, microscopic examination of
the tissue sections showed that the pattern of AM expression basically mirrored that of
the peptide antigen staining (Fig. 5) observed with immunohistochemistry in normal and
infected tissue. However, in association with experimental infection withE. coli, AM mRNA
product staining was increased not only in the clustered infiltrating SCCs and the lumen
Fig. 6. Adrenomedullin mRNA expression patterns visualized by in situ hybridization in mammary biopsy samples
collected from lactating cows (n = 3) each with one quarter challenged with saline and another quarter challenged
with E. coli. Specific dark gray-to-black staining was generated by the alkaline phosphatase-associated reporter
coupled to anti-digoxigenin where the digoxygenin-coupled riboprobe hybridized to the endogenous AM mRNA
(middle and right panels). The digoxygenin-labeled sense probe (left panel) failed to generate significant signal
and was used to correct for nominal background in the image analysis process.
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boarder epithelial cells, but also in stromal cells within the tissue matrix and in association
with several of the blood vessels present in the various sections.
4. Discussion
As relates to the periparturient cow and its varying levels of immunocompetence, we
asked whether tissue-specific changes in AM and its binding protein AM-BP are localized
to the mammary gland or associated with differences in milk content at a given stage of
lactation. Using in situ hybridization and sensitive quantitative immunohistochemical tech-
niques for tissue analysis as well as Western blot and radioimmunoassay for AM-BP and
AM in milk, respectively, we discovered that there was a significant change in the content of
AM and AM-BP, in mammary alveolar cells, there was little change in milk concentrations
of AM, but significant change in milk AM-BP as a function of lactation stage. Perhaps the
greatest factor affecting milk concentrations of AM and AM-BP was the presence of infil-
trating neutrophils (somatic cells) suggesting some level, albeit low, of invasion by a foreign
body (bacteria or otherwise). In general, a higher level of SCC was associated with a higher
level of AM and AM-BP. The data in this report that address the relationship between SCC
and adrenomedullin are for milk collected from cows in the herd irrespective of bacteriolog-
ical status. Milk was normal in appearance, without flakes or clots. Evaluation of AM over
a range of SCC was done without regard to bacteriological status of the quarters. Visual
examination of the hematoxylin/eosin-stained histological sections suggest that the vast
majority of SCC were neutrophils, i.e. their size, intracellular morphology and polymor-
phic nuclei were consistent with a predominance of neutrophillic infiltration. Comparing
tissues obtained from cows in different stages of lactation, we observed that the lowest level
of expressed AM in the mammary gland occurred in tissue sections obtained from cows
during the dry period and shortly after calving. Similarly, introduction of a pathogen (E.
coli) to the mammary gland resulted in increased transcript levels for AM and accompany-
ing increases in tissue associated AM antigen. Interestingly, infiltrating cells presented the
highest AM antigen density in the infected alveoli with the second highest level of expres-
sion present on luminal surface of epithelial cells lining the mammary alveoli on the luminal
surface. The determination of success in eliminating inherent SCC-associated peroxidase
activity provided further validation of the greater intensity of antigen presence in these cells.
The present data confirms and extends our previous data [20] on relative AM content in
milk with the tissue data on AM and AM-BP. Furthermore, the milk AM data presented here
support the previous observation that milk AM concentrations were relatively stable across
days of lactation. With regard to E. coli infection of the mammary gland, a prominent fea-
ture of the staining pattern was the tight association of antigen (granules) with the luminal
surface of the epithelial cells suggesting secretion of AM or externalization of AM to the
outside surface where the peptide would be more directly exposed to the pathogen, possibly
leading to protection of affected alveolar epithelial cells. The report by Welsh et al. [35]
supports this concept wherein they described the presence of AM in the apical protrusions
of human breast epithelium, being secreted to the lumen by an apocrine mechanism.
The time around calving is recognized as a period of increased disease incidence in
cows [22,23,36–38]. Periparturient susceptibility to disease is attributed to residual degrees
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of compromised immune functions that persist as a carryover from hormone and cytokine
interactions that were needed to maintain pregnancy (i.e., pregnancy-related immunosup-
pression to prevent embryonic allograph rejection by maternal tissues, [38,39]), but are in
fact in the process of being downregulated as fetal maturation signals prompt the initia-
tion of separation of the calf from the mother at parturition [40]. Present day management
strategies of cows during this transition period call for health maintenance through antibi-
otic regimens as well as nutritional strategies to lessen the impact of metabolic syndromes
that can potentiate additional sensitivity to infection by opportunistic bacteria, especially
with regard to intramammary infection [41]. Our laboratory has been interested in how
novel aspects of innate or naturally present defense mechanisms might be better exploited
in cows to improve the chances for more rapid and beneficial outcome from exposures to
pathogens in this critical period. Our experience has suggested that endogenous multifunc-
tional peptides, when upregulated during periods of stress, bridge and coordinate effects
on metabolism and immune function, and yet having novel antimicrobial activity, serve
as important biomarkers that can be utilized for selecting breeding animals with desirable
production and health traits [6,38].
Adrenomedullin is now recognized as a key peptide in many tissues in many species that
serves as a coordinating tissue survival factor in many species during decompensating stress
[6,7,42]. Examples of activity include its capacity to ameliorate regional ischemic events and
blood shunting during sepsis by maintaining local tissue oxygen perfusion and blood flow
[43], reducing tissue necrosis and apoptosis through AM/AM-BP complex-augmented pro-
duction of anti-apoptotic BCL-2 cascade factors and concomitantly decreased pro-apoptotic
Bax gene expression [44], effects on pancreatic hormone secretion and localized tissue
metabolic responses to pancreatic hormones [13,29,30], interactions with the LPS—TNF-
–nitric oxide cascade [12,13,38], and its effects to neutralize growth and pathogenic
activities of both Gram-negative and Gram-positive [8–10] bacteria.
Collectively, the present data indicate that tissue and milk levels of AM and AM-BP
change throughout the lactation cycle especially as affected by underlying conditions that
promote the migration of infiltrating somatic cells into the mammary alveoli. The general-
ized upregulation (i.e., increased tissue antigen presence) of AM and AM-BP in association
with increased somatic cell count suggests that in cases of very low level foreign body chal-
lenge (inert particulate, pathogen or otherwise) there exists a tight coordination between
these factors that may play a role in the acute and chronic maintenance of udder health.
When the inflammatory state develops, as experimentally induced here by the infusion
of E. coli, there appears to develop a functional disconnect between AM and AM-BP,
such that direct effects of AM on host immune processes are increased not only though
increased AM production, but in addition through a decreased association of AM with its
binding protein. This is consistent with previous observations clearly showing that many
physiological actions of AM are prevented from occurring when AM is bound to its bind-
ing protein, as is the ability of AM-BP, complement factor-H, to modulate aspects of the
complement cascade [17,18]. A key example of this was demonstrated when exogenous
AM-BP was added to AM causing a significant portion of the antibacterial effect of AM
to be lost. Conversely, if tissue levels of endogenous AM-BP are decreased and AM pep-
tide increased in mammary tissue and infiltrating cells during coliform mastitis, then it
stands to reason that the potential for beneficial effects of AM-driven antimicrobial control
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of mastitis are increased, likely complementing other innate countermeasures that may be
similarly affected. In line with this direct effect on bacteria [9,10], the upregulation of AM
is consistent with other homeostatic actions of AM, some in part mediated by the action of
AM to increase local production of nitric oxide. They include increased mammary blood
flow facilitating delivery of neutrophils, complement factors and chemotactic factors to the
gland stabilization and attenuation of bacterial toxin-related apoptosis, counter-regulation
of adverse proinflammatory cytokine release, and facilitated augmentation of growth factor
production including IGF-1 [38,43,45–48]. Exactly how AM affects the biological activity
of AM-BP towards processing of complement C3 and the progression through the com-
plement cascade towards complement C5-mediated chemotactic attraction of monocytes,
granulocytes and neutrophils [49] to sites of mammary infection remains unknown.
With regard to the immunolocalization of AM in mammary cells and structures, a promi-
nent feature of the staining pattern was the tight association of antigen (granules) with the
luminal surface of the epithelial cells. This would be consistent with a process involving
secretion of AM or externalization of AM to the outside surface where the peptide would
be more directly exposed to the pathogen in a mechanism protective to the affected mam-
mary gland cells. We consider the antimicrobial actions of AM significant with regard to
the potential for the mammary gland to help itself in times of incurred pathogen challenge
through the local production of an endogenous peptide such as AM. Allaker et al. [50]
investigated the mechanism by which AM exerts many of its antimicrobial properties. In
essence, AM generates pore formation and cell wall disruption in E. coli. Processing of
AM may be an important determinant of AM antimicrobial activity in that differences in
minimal inhibitory concentrations (MIC) were associated with different molecular forms
of the native 52 amino acid. In particular, the fragments of AM with greatest antimicrobial
activity were AM13–52 and AM16–52, the carboxy terminal region having more activity than
amino-terminal areas. Suggested in this research was the idea that post-secretory process-
ing generates a myriad of AM subsets with a range of targets. This multiform approach to
antimicrobial activity may reduce the likelihood of the development of resistance. Further-
more, this processing to fragments of AM underscores the relevance of the total AM-like
immunoreactivity concentrations reported here for milk in contrast to the lower levels of
AM in milk reported by Ohta et al. [51] using an immunoradiometric assay that presumably
quantified presumable only one form of AM. However, the higher levels of AM reported
for milk in the present study may reflect a fundamental species difference in expression,
secretion and processing.
Depending on the biological effect observed, the interaction of AM with AM-BP can
facilitate or retard the action of each component in the complex. For example, a reciprocal
interaction is imparted on biological properties of AM when it is bound to the complement
factor-H binding protein. AM antimicrobial peptide activity against E. coli is significantly
reduced when AM is linked to its binding protein. Pio et al. [17] demonstrated that the
minimal inhibitory concentration of AM effective against E. coli shifted from 10 to more
than 35g/ml when AM was complexed with AM-BP. Interestingly, the activity of AM-
BP as complement factor-H (responsible cofactor for the factor I-dependant cleaving of
complement C3B) is increased when AM is bound [17] suggesting that aspects of the
innate complement cascade within the mammary gland [49] are also modulated by AM.
Furthermore, increased beneficial clinical outcome (decreased morbidity and mortality)
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recently has been attributed to the use of an AM/AM-BP complex as an intervention strategy
to limit the complicating effects of sepsis and hypovolumic shock on progression into
multiple organ failure [19,42–44].
The importance of these observations relate to the inherent capacity for the mammary
gland to mount defenses against invading pathogens that could trigger clinical mastitis. This
defense may include the local production of inflammatory cytokines [52], generation of
superoxide anion via mammary xanthine oxidase [53] and nitric oxide [47,54,55]. First, the
tissue content of AM as an antimicrobial peptide capacity of AM is lowest at the time when
it is most needed. This is also the case for lactoferrin and other endogenous peptides in milk
[38] that, as a collective milieu, form one of the basic compartmentalized local mediators
of mammary tissue health, not unlike that present in epidermal skin, the respiratory tract,
and even the GI tract [9]. In this regard, we can also envision a potential compromise of the
nitric oxide and superoxide anion defense mechanisms since these are also lowest at this
time period, though presently this area of mammary biology in the bovine is poorly studied.
In addition, the tightly coordinated regulation of AM and nitric oxide make a strong case
for blood flow in the mammary gland is regulated by the local production of these vascular
mediators [47]. The data presented here extend our knowledge of AM in cattle and serve
as a launch point for further investigation regarding the merit of using AM and AM-BP as
biomarkers for mammary health and their utility for selecting animals with an improved
capacity to resist mastitis through endogenous mechanism.
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